Erbabacan Emre, Köksal Güniz M, Şeker Tuğçe Barça, Ekici Birsel, Özcan Rahsan, Altindaş Fatiş
Department of Anaesthesiology and Reanimation, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Department of Paediatric Surgery, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Turk J Anaesthesiol Reanim. 2015 Oct;43(5):356-9. doi: 10.5152/TJAR.2015.22448. Epub 2015 Aug 21.
Here, we report anaesthesia management and the successful use of total intravenous anaesthesia and sugammadex in a patient with Ullrich's disease. Propofol and remifentanyl infusion was used for anaesthesia. After the end of the surgery, when the train-of-four value was 0%, 4 mg kg(-1) sugammadex was administered, and the patient was successfully extubated after 36 s. No adverse effects or safety concerns were observed. In conclusion, we suggest that the use of propofol infusion to avoid the use of inhalation anaesthetics and the use of sugammadex for the reversal of the effects of rocuronium is safe in patients with Ullrich's disease.
在此，我们报告了对一名患有乌尔里希氏病患者的麻醉管理以及全静脉麻醉和舒更葡糖的成功应用。采用丙泊酚和瑞芬太尼输注进行麻醉。手术结束后，当四个成串刺激值为0%时，给予4 mg·kg⁻¹舒更葡糖，36秒后患者成功拔管。未观察到不良反应或安全问题。总之，我们建议在乌尔里希氏病患者中，使用丙泊酚输注以避免使用吸入性麻醉剂，并使用舒更葡糖来逆转罗库溴铵的作用是安全的。
